Clinical Trials | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
WINLEVI works differently from any other topical acne treatment
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Subscribe To Our Newsletter & Stay Updated
